🇺🇸 FDA
Patent

US 7615223

Selected immunoconjugates for binding to aminophospholipids

granted A61KA61K2039/505A61K39/395

Quick answer

US patent 7615223 (Selected immunoconjugates for binding to aminophospholipids) held by The Board of Regents of the University of Texas System expires Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
64
CPC classes
A61K, A61K2039/505, A61K39/395, A61K39/39558, A61K47/62